Diabetes Refill Cost · 2026 Pricing
Diabetes Medication Refill Cost: Online Doctor vs Primary Care vs Endocrinologist
Metformin is $5.75/month. A telehealth diabetes refill visit is $79. For a stable T2DM patient with well-controlled A1C who needs prescription continuity, the $79 visit is all that stands between you and your medication, no specialist waitlist required.
Board-certified MD · 44 states + DC · evenings & weekends · HSA/FSA accepted · 4.97★ (173 reviews)
Diabetes Refill Visit at TeleDirectMD: $79
flat self-pay · insurance not required
- Same-day video visit with a board-certified MD
- Metformin, SGLT-2 inhibitor, or GLP-1 refill prescription sent to pharmacy
- A1C trend review and target counseling (ADA 2026 guideline-based)
- GoodRx coupon guidance for branded medications, Jardiance, Farxiga
- Civica Rx insulin referral for uninsured insulin-dependent patients
- HSA/FSA accepted, 44 states, evenings & weekends
Diabetes medication refill cost in 2026 (cash-pay totals):
A telehealth diabetes refill visit at TeleDirectMD costs $79. Generic metformin 500mg (60 tablets) starts at $5.75–$9/month via GoodRx (April 2026). Branded SGLT-2 inhibitors remain expensive: Jardiance 10mg is ~$355/month and Farxiga 10mg is ~$288/month with GoodRx coupons (GoodRx; GoodRx, April 2026). Civica Rx biosimilar insulin is now available at ≤$30/vial as of January 2026 (Civica Rx, January 2026). Compare to an endocrinology office visit at $200–$400 cash-pay, without changing the medication.
Type 2 diabetes is one of the most manageable and most expensive chronic conditions in the US, expensive not because the first-line medication (metformin) is costly, but because SGLT-2 inhibitors, GLP-1 agonists, and insulin all carry high price tags without insurance, and specialist access is limited. For a patient with stable, well-controlled T2DM who simply needs a refill and A1C monitoring, telehealth is both clinically appropriate and dramatically cheaper than a specialist visit. We pulled 2026 pricing from GoodRx, Civica Rx, and standard benchmarks to show exactly what diabetes medication management costs across care settings, and where the value opportunities are.
The numbers
Diabetes Medication Refill Cost by Care Setting (2026, Cash-Pay Total)
Visit cost + one month of first-line medication. SGLT-2 and insulin costs listed separately due to wide range. Generic metformin assumed as baseline medication.
| Setting | Cost | What's included |
|---|---|---|
| TeleDirectMD (online) | $55–$64 typical | $79 visit + metformin ($5.75–$9), SGLT-2 inhibitor refill at same visit if applicableTeleDirectMD; GoodRx |
| Telehealth (national average) | $85–$93 | Visit ($40–$100) + metformin ($5.75–$9)GoodRx; BetterCare 2025 |
| Primary care (cash-pay) | $115–$275 | In-person visit ($110–$265) + metformin ($5.75–$9); A1C lab may add $20–$50Mira Health, 2025 |
| Urgent care (in-person) | $180–$360 | Not the appropriate setting for stable diabetes refills; listed for contextBetterCare, 2025 |
| Retail clinic (CVS MinuteClinic) | $105–$153 | NP visit; MinuteClinic handles simple refills including diabetes medicationsCVS MinuteClinic, 2024 |
| Endocrinologist (cash-pay) | $200–$400 | Specialist visit; typically 6–12 week wait; medications cost same regardless of prescriberBetterCare, 2025 |
Why the difference
Diabetes Medication Costs: The Tier 1 Foundation, the SGLT-2 Reality, and Civica Insulin
The ADA 2026 Standards of Care continue to endorse metformin as first-line therapy for most adults with type 2 diabetes, effective, safe, weight-neutral-to-favorable, and inexpensive. According to GoodRx (April 2026), generic metformin 500mg (60 tablets, a typical 30-day supply) starts at $5.75–$9 at most US pharmacies, solidly in the Tier 1 ($4–$15) range. Many pharmacies offer metformin as part of $4/$10 generic programs. For the majority of new T2DM diagnoses, a telehealth evaluation and metformin prescription is the entire clinical transaction, total cost under $60. The ADA 2026 layered approach adds SGLT-2 inhibitors or GLP-1 agonists when cardiovascular, renal, or hepatic risk warrants it, not sequentially over years, but risk-stratified from early in the treatment course.
SGLT-2 inhibitors (Jardiance, Farxiga) add meaningful cardiovascular and renal protection in appropriate patients but carry significant cost. According to GoodRx (April 2026), Jardiance (empagliflozin) 10mg costs approximately $355/month with a coupon (retail $422+/month), and Farxiga (dapagliflozin) 10mg is ~$288/month with GoodRx (GoodRx Jardiance; GoodRx Farxiga). Manufacturer savings cards (AstraZeneca for Farxiga, Lilly/Boehringer for Jardiance) can reduce cost to $0–$35/month for commercially insured patients who qualify. For uninsured patients, these remain a significant monthly burden. Penn Medicine's 2026 JAMA Network Open study found telehealth averaged $96 vs. $509 in-person (Penn Medicine, 2026), the medication cost, not the visit type, drives the total diabetes management spend.
Insulin access received a major affordability breakthrough in January 2026: Civica Rx (CivicaScript), a nonprofit pharmaceutical manufacturer, launched biosimilar long-acting and short-acting insulin products at a recommended consumer price of no more than $30 per vial and no more than $55 for a box of five prefilled pens. This is a transformative price point: branded long-acting insulins (Lantus, Toujeo, Basaglar) have historically retailed at $200–$400/vial. Civica's insulin is available at pharmacies that have joined the CivicaScript network. For insulin-dependent patients without adequate coverage, the telehealth provider can identify the nearest participating pharmacy and write the appropriate biosimilar prescription.
Who benefits
Who Benefits Most From a Telehealth Diabetes Refill Visit
Newly diagnosed T2DM patients without an endocrinologist
ADA-endorsed: most new T2DM diagnoses are manageable in primary care or telehealth with metformin + lifestyle. No specialist required for uncomplicated presentations.
Stable T2DM patients who simply need a refill
Well-controlled A1C (< 7.5%), on a stable regimen, no new symptoms? A $79 telehealth visit provides continuity of care without the wait or cost of an endocrinology appointment.
Uninsured patients on insulin
Civica Rx biosimilar insulin is ≤$30/vial as of January 2026. A telehealth provider can identify participating pharmacies and write the Civica-compatible prescription.
Patients struggling with SGLT-2 inhibitor costs
Jardiance at $355/month and Farxiga at $288/month are manageable with manufacturer savings cards, which require a commercial insurance attestation. A telehealth visit helps navigate the savings card eligibility.
Is it right for you?
When Diabetes Management Belongs in Telehealth vs. In-Person
Good fit for a video visit
- Stable T2DM with well-controlled A1C and no new symptoms, medication refill only
- Metformin initiation for new T2DM or prediabetes diagnosis
- SGLT-2 inhibitor or GLP-1 refill with no complications or side effects
- A1C trend review and counseling against ADA 2026 targets (< 7% for most adults)
- Insulin dose adjustment for patients on a stable regimen, glucose log review
- Lifestyle counseling and MNT (medical nutrition therapy) referral
Better seen in person
- Diabetic ketoacidosis (DKA), ER immediately; life-threatening emergency
- Hyperosmolar hyperglycemic state (HHS), ER immediately
- New foot ulcer, non-healing wound, or signs of peripheral vascular disease
- New visual changes, chest pain, or signs of acute diabetic complications
- Frequent unexplained hypoglycemia requiring insulin regimen overhaul
- First insulin initiation in T1DM or complex T2DM, in-person diabetes education program preferred
Decision guide
Diabetes: Telehealth Refill, Primary Care, or ER?
DKA symptoms: vomiting, fruity breath, confusion, high glucose?
Go to the ER immediately. Diabetic ketoacidosis is a life-threatening emergency requiring IV insulin, fluids, and electrolyte monitoring.
Stable T2DM, well-controlled A1C, just need a refill?
Book a $79 telehealth visit. Metformin refill + SGLT-2 or GLP-1 continuation: total visit cost $79. Ongoing medication costs depend on your formulary.
New foot wound, vision changes, or kidney symptoms?
See a primary care provider or specialist in person. These may signal diabetic complications requiring physical exam, imaging, or labs beyond a refill visit.
On insulin, running out and uninsured?
A telehealth visit can prescribe Civica Rx biosimilar insulin (≤$30/vial) and identify the nearest participating pharmacy. Do not ration insulin, contact a provider or FQHC immediately if you are at risk of running out.
Medication pricing
Diabetes Medication Costs (GoodRx Cash Price and Civica Rx, 2026)
30-day supply at major retail pharmacy. SGLT-2 prices reflect GoodRx coupon. Manufacturer savings cards may further reduce SGLT-2 costs for commercially insured patients.
| Medication | Cost |
|---|---|
| Metformin 500mg–1000mg, ADA 2026 first-line, Tier 1 generic | $5.75–$9/monthsource |
| Jardiance (empagliflozin) 10mg, SGLT-2, cardiovascular/renal benefit | ~$355/month with GoodRx coupon ($422+ retail)source |
| Farxiga (dapagliflozin) 10mg, SGLT-2, cardiovascular/renal/HF benefit | ~$288/month with GoodRx coupon (~$600 retail)source |
| Civica Rx biosimilar insulin (long-acting), launched January 2026 | ≤$30/vial (no more than $55 for 5-pen box)source |
| Glipizide (sulfonylurea, generic), alternative oral agent | ~$10–$15/monthsource |
Common questions
Frequently asked questions
How much does diabetes medication cost without insurance in 2026?
It depends sharply on which medication. Generic metformin, the ADA's 2026 first-line recommendation, costs as little as $5.75–$9/month via GoodRx (April 2026). A telehealth refill visit is $79, total under $60. SGLT-2 inhibitors are more expensive: Jardiance 10mg runs ~$355/month and Farxiga 10mg ~$288/month with GoodRx coupons. Civica Rx biosimilar insulin is now available at ≤$30/vial as of January 2026.
What is the cheapest diabetes medication available in 2026?
Generic metformin is the clear answer, as low as $5.75/month (60 tablets) via GoodRx (April 2026), and available on $4/$10 generic programs at many chain pharmacies. It is also the ADA 2026 guideline-recommended first-line therapy for most adults with type 2 diabetes. Glipizide (generic sulfonylurea) is similarly cheap at $10–$15/month but carries hypoglycemia risk.
What is Civica Rx insulin and how affordable is it?
Civica Rx is a nonprofit pharmaceutical manufacturer that launched biosimilar insulin products in January 2026 at a recommended consumer price of no more than $30 per vial and no more than $55 for a box of five prefilled pens (Civica Rx, January 2026). This compares to $200–$400/vial for branded long-acting insulins. Civica insulin is available at pharmacies in the CivicaScript network, ask your TeleDirectMD provider for the nearest participating location.
Does insurance cover Jardiance or Farxiga?
Most commercial plans cover SGLT-2 inhibitors, typically on Tier 3 (specialty tier), with copays of $40–$100/month for insured patients who have met their deductible. Manufacturer savings cards (AstraZeneca's Farxiga card, Lilly/Boehringer's Jardiance card) can reduce cost to $0–$35/month for commercially insured patients who qualify. For uninsured patients, GoodRx brings Jardiance to ~$355/month and Farxiga to ~$288/month, still a significant cost.
Can a telehealth doctor refill my diabetes medications?
Yes, for stable, controlled T2DM. A TeleDirectMD provider can refill metformin, SGLT-2 inhibitors, oral GLP-1s (semaglutide tablets), and insulin prescriptions in a $79 visit. Insulin initiation, complex regimen changes, and new complications warrant in-person care.
What are ADA 2026 guidelines for diabetes treatment?
ADA 2026 Standards of Care recommend a layered approach: (1) lifestyle optimization first, Mediterranean dietary pattern, structured aerobic exercise; (2) metformin as the preferred first medication for most adults with T2DM; (3) early addition of SGLT-2 inhibitors or GLP-1 receptor agonists when cardiovascular, renal, or obesity risk warrants it, not sequentially over years, but risk-stratified from early treatment. Continuous glucose monitoring is now recommended earlier and more broadly, including older adults on insulin.
When should a diabetic patient go to the ER vs. use telehealth?
Go to the ER for: symptoms of DKA (vomiting, fruity breath, confusion, blood glucose > 300 mg/dL), hyperosmolar hyperglycemic state, or any acute diabetic complication. Telehealth is appropriate for: stable refills, A1C counseling, minor medication adjustments, and lifestyle coaching when the patient feels clinically well with no acute symptoms.
Is a telehealth visit appropriate for A1C monitoring in diabetes?
Yes, with caveats. A TeleDirectMD provider can order an A1C blood draw at a local lab (Quest, LabCorp) at the $79 telehealth visit, review results remotely, and adjust medications accordingly. Home A1C test kits are also available OTC for ~$30–$40. A telehealth visit cannot perform in-person foot exams or retinal screening, those still require periodic in-person evaluations annually per ADA guidelines.
Explore more
Related pricing & comparisons
Clinical & pricing sources
References
- GoodRx, Metformin pricing (April 2026)
- GoodRx, Jardiance pricing (April 2026)
- GoodRx, Farxiga pricing (April 2026)
- Civica Rx, Medications and insulin pricing (January 2026)
- ADA, Standards of Care in Diabetes 2026
- ADA, Pharmacologic approaches to glycemic treatment (PMC/Diabetes Care 2025)
- BetterCare, Urgent care and ER cost (2025)
- Mira Health, Primary care cost without insurance (2025)
- Penn Medicine, Telemedicine vs. in-person costs, JAMA Network Open (2026)
- CVS MinuteClinic, Price list (2024)
See a board-certified MD today
A flat $79 video visit. No insurance required, prescription sent to your pharmacy same-day.
Book a Visit, $79 →